Joyner’s comments were his first made publicly since he was promoted less than a month ago to replace Karen S. Lynch, who stepped down. CVS Health has struggled to control costs in its Aetna health ...

Charles Rhyee, an analyst from TD Cowen, maintained the Buy rating on CVS Health (CVS – Research Report). The associated price target was ...

CVS Health (NYSE: CVS, $67.46, Market Capitalization: $84.86 billion), a leading health solutions company in the US, is considering a potential break-up to separate its retail and insurance units.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

CVS Health recently acquired home healthcare agency, Signify Health, for a whopping $8 billion.With the biggest players across the healthcare industry interested in making an offer, I only expect ...

CVS Health will report third-quarter earnings before the market opens Wednesday as the pharmacy and health-care provider ...

CVS Health said Friday CEO Karen Lynch has stepped down after the pharmacy chain once again warned its earnings will fall short of Wall Street's forecasts. Lynch will be replaced by CVS Caremark ...

CVS Health Corp. faces continued challenges in its insurance business, prompting the company to shake up its management ranks in a bid to get back on track. Shares of the pharmacy and healthcare ...

CVS Health has replaced Karen Lynch with David Joyner as CEO, it said Friday, part of an attempt to turn the struggling company around. Joyner was previously the president of CVS Caremark, ...

In this article, we are going to take a look at where CVS Health Corporation (NYSE:CVS) stands against the other most profitable value stocks to invest in. Value investing is essentially focused ...